Novartis Ag (NVS) Change in Inventory (2022 - 2026)

Novartis Ag's Change in Inventory history runs 5 years deep, the most recent figure standing at -$95.0 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 272.73% year-over-year to -$95.0 million; the TTM figure through Mar 2026 stood at -$134.0 million (up 35.58% YoY), while the FY2025 annual figure was $34.0 million, changed N/A from the prior year.
• Change in Inventory came in at -$95.0 million for Q1 2026 at Novartis Ag, down from $34.0 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $90.0 million in Q3 2024 to a low of -$514.0 million in Q4 2022.
• A 5-year average of -$154.9 million and a median of -$128.0 million in 2024 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory soared 372.73% in 2024 and plunged 272.73% in 2026, its largest moves.
• Novartis Ag's Change in Inventory stood at -$514.0 million in 2022, then soared by 93.58% to -$33.0 million in 2023, then tumbled by 581.82% to -$225.0 million in 2024, then jumped by 115.11% to $34.0 million in 2025, then slumped by 379.41% to -$95.0 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$95.0 million, $34.0 million, and -$128.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison